Citric Acid Cycle (TCA Cycle)

Citric Acid Cycle (TCA Cycle)

Introduction

The Citric Acid Cycle, also known as the Tricarboxylic Acid (TCA) Cycle or Krebs Cycle, is a central metabolic pathway located in the mitochondrial matrix(/mitochondria)](/mitochondria). It serves as the hub of cellular metabolism, oxidizing acetyl-CoA derived from carbohydrates, fats, and to generate high-energy electron carriers (NADH and FADH₂) that fuel ATP production through the Electron Transport Chain. In [neurons](/entities/neurons)—neurons—highly energy-demanding cells with limited regenerative capacity—proper TCA cycle function is critical for maintaining synaptic activity, membrane potentials, and cellular homeostasis. Dysregulation of this cycle is increasingly recognized as a key contributor to neurodegeneration in Alzheimer's disease (AD), Parkinson's disease (PD), Amyotrophic Lateral Sclerosis (ALS), and Huntington's disease (HD) 1. [@gibson2020]

TCA Cycle in Neurodegeneration

Overview

Citric Acid Cycle (TCA Cycle)

Introduction

The Citric Acid Cycle, also known as the Tricarboxylic Acid (TCA) Cycle or Krebs Cycle, is a central metabolic pathway located in the mitochondrial matrix(/mitochondria)](/mitochondria). It serves as the hub of cellular metabolism, oxidizing acetyl-CoA derived from carbohydrates, fats, and to generate high-energy electron carriers (NADH and FADH₂) that fuel ATP production through the Electron Transport Chain. In [neurons](/entities/neurons)—neurons—highly energy-demanding cells with limited regenerative capacity—proper TCA cycle function is critical for maintaining synaptic activity, membrane potentials, and cellular homeostasis. Dysregulation of this cycle is increasingly recognized as a key contributor to neurodegeneration in Alzheimer's disease (AD), Parkinson's disease (PD), Amyotrophic Lateral Sclerosis (ALS), and Huntington's disease (HD) 1. [@gibson2020]

TCA Cycle in Neurodegeneration

Overview

The TCA cycle consists of eight enzyme-catalyzed reactions that completely oxidize acetyl-CoA to two molecules of CO₂ while capturing energy in the form of NADH, FADH₂, and GTP. This cycle not only generates ATP but also provides metabolic intermediates for biosynthesis, including amino acids, porphyrins, and lipids. In the brain, the TCA cycle is particularly important because: [@attwell2001]

Reactions and Enzymes

1. Citrate Synthase (CS)

Citrate synthase catalyzes the condensation of acetyl-CoA with oxaloacetate to form citrate. This is the rate-limiting step of the TCA cycle and is allosterically inhibited by ATP, NADH, and succinyl-CoA, while activated by ADP and Ca²⁺ 3. In AD, reduced CS activity has been reported in the [hippocampus](/brain-regions/hippocampus) and temporal [cortex](/brain-regions/cortex), contributing to impaired energy metabolism 4. [@bubber2004]

2. Aconitase (ACO2)

Aconitase catalyzes the isomerization of citrate to isocitrate through a dehydration/hydration mechanism. The enzyme contains an iron-sulfur 4Fe-4S cluster that is highly sensitive to oxidative stress. In neurodegeneration, mitochondrial aconitase (ACO2) is a known target of [reactive oxygen species](/entities/reactive-oxygen-species) (ROS), and mutations in ACO2 cause hereditary spastic paraplegia and cerebellar ataxia 5. [@waitkus2013]

3. Isocitrate Dehydrogenase (IDH3)

Isocitrate dehydrogenase (IDH3) is the NAD⁺-dependent enzyme in the TCA cycle, generating NADH. IDH3 is allosterically activated by ADP and inhibited by ATP and NADH. Notably, IDH1 (cytosolic) and IDH2 (mitochondrial) are frequently mutated in cancers, but in neurodegeneration, loss-of-function mutations in IDH1 are associated with reduced α-ketoglutarate levels and impaired [DNA methylation](/entities/dna-methylation) 6. [@mizuno1990]

4. α-Ketoglutarate Dehydrogenase Complex (α-KGDHC)

The α-ketoglutarate dehydrogenase complex is a key regulatory point in the TCA cycle and is particularly vulnerable in neurodegeneration. α-KGDHC requires thiamine pyrophosphate (TPP) as a cofactor, explaining why thiamine deficiency (seen in Wernicke-Korsakoff syndrome) impairs the TCA cycle 7. In AD and PD brains, α-KGDHC activity is significantly reduced in affected regions, contributing to metabolic failure 8. [@bayley2010]

5. Succinyl-CoA Synthetase (SCS)

Succinyl-CoA synthetase (also called succinate thiokinase) generates GTP (or ATP) through substrate-level phosphorylation. This is the only step in the TCA cycle that directly produces high-energy phosphate. Two isoforms exist: SCS-GDP (brain-specific) and SCS-ATP (ubiquitous) 9. [@minden1974]

6. Succinate Dehydrogenase (SDH / Complex II)

Succinate dehydrogenase (SDH) is unique among TCA cycle enzymes because it is also a component of the Electron Transport Chain (Complex II). SDH deficiency is a hallmark of PD, where Complex I inhibition indirectly affects SDH function. Germline SDH mutations cause hereditary paraganglioma and pheochromocytoma 10.

7. Fumarase (FH)

Fumarase (fumarate hydratase) catalyzes the hydration of fumarate to malate. Loss-of-function mutations in FH cause hereditary fumarase deficiency, leading to severe neurological deficits, including microcephaly and seizures. In cancer, FH deficiency leads to fumarate accumulation, which inhibits α-ketoglutarate-dependent dioxygenases, causing epigenetic dysregulation 11.

8. Malate Dehydrogenase (MDH2)

Malate dehydrogenase completes the cycle by regenerating oxaloacetate while generating NADH. The reaction is highly unfavorable (ΔG°' = +29.7 kJ/mol) and is driven forward by the subsequent citrate synthase reaction. MDH2 is also part of the malate-aspartate shuttle, which transfers cytosolic NADH electrons into mitochondria 12.

Regulatory Mechanisms

Allosteric Regulation

• ATP/NADH inhibition: High energy charge (high ATP/NADH) inhibits CS, IDH3, and α-KGDHC
• ADP/AMP activation: Low energy charge activates IDH3 and CS
• Ca²⁺ activation: Calcium ions (signaling molecule in active neurons) activate IDH3, α-KGDHC, and CS

Transcriptional Regulation

• PGC-1α: Peroxisome proliferator-activated receptor gamma coactivator 1-alpha regulates mitochondrial biogenesis, including TCA cycle enzymes
• SIRT1/3: NAD⁺-dependent deacetylases regulate enzyme activity (e.g., SIRT3 deacetylates IDH2 and SDH)

Integration with Other Pathways

• Anaplerosis: Input of substrates (pyruvate, glutamate, propionate) to replenish TCA intermediates
• Cataplerosis: Removal of intermediates for biosynthesis
• Malate-aspartate shuttle: Transfers cytosolic NADH into mitochondria

Neurodegeneration Relevance

Alzheimer's Disease

• Reduced TCA cycle activity: Post-mortem studies show 30-50% reduction in CS, IDH, and α-KGDHC activity in AD hippocampus 4
• α-KGDHC vulnerability: This enzyme is particularly sensitive to oxidative stress and amyloid-β toxicity
• Glucose hypometabolism: FDG-PET shows reduced cerebral glucose uptake in AD, reflecting impaired TCA cycle function
• α-Ketoglutarate depletion: Reduced α-ketoglutarate levels impair astrocyte-neuron lactate shuttle and neurotransmitter synthesis

Parkinson's Disease

• Complex I deficiency: Inhibition of Complex I (NADH oxidation) indirectly reduces TCA cycle flux
• α-KGDHC reduction: Significant reduction in α-KGDHC activity in substantia nigra of PD patients 8
• Fumarate accumulation: Impaired SDH function leads to fumarate accumulation and succinate elevation

Amyotrophic Lateral Sclerosis (ALS)

• Metabolic dysfunction: ALS patients show reduced TCA cycle enzyme activity in skeletal muscle and motor cortex
• Glutamate excitotoxicity: Impaired α-KGDHC reduces glutamate oxidation, potentially contributing to excitotoxicity
• [C9orf72](/entities/c9orf72) expansion: Affects mitochondrial function and TCA cycle regulation

Huntington's Disease

• Energy deficit: Mutant [huntingtin](/entities/huntingtin-protein) impairs mitochondrial function and TCA cycle activity
• α-KGDHC reduction: Reduced α-KGDHC activity in HD striatum and cortex
• Creatine deficiency: ATP depletion in HD reflects impaired TCA cycle function

Other Neurodegenerative Conditions

• Leigh Syndrome: Pyruvate dehydrogenase and Complex I deficiencies cause severe TCA cycle impairment
• Friedreich's Ataxia: Frataxin deficiency impairs iron-sulfur cluster assembly, affecting aconitase
• Multiple System Atrophy (MSA): Mitochondrial dysfunction affects TCA cycle in affected brain regions

Therapeutic Implications

Metabolic Enhancers

• Thiamine (Vitamin B1): TPP precursor to enhance α-KGDHC activity 13
• Alpha-ketoglutarate supplementation: May support TCA cycle function and reduce excitotoxicity
• CoQ10: Supports electron transport chain, indirectly enhancing TCA cycle turnover

Mitochondrial Biogenesis

• PGC-1α agonists: Exercise, resveratrol, and bezafibrate enhance mitochondrial biogenesis
• NAD⁺ boosters: NMN, NR increase SIRT1/3 activity, enhancing TCA cycle regulation

Antioxidant Strategies

• MitoQ: Mitochondrial-targeted antioxidant to protect iron-sulfur enzymes
• Edaravone: Free radical scavenger approved for ALS

Gene Therapy Approaches

• AAV-mediated enzyme delivery: Potential for delivering functional TCA cycle enzymes
• mtDNA restoration: For primary mitochondrial affecting TCA cycle

Biomarkers

Metabolic Biomarkers

• Blood/CSF α-ketoglutarate: Reduced levels indicate TCA cycle impairment
• Lactate/pyruvate ratio: Elevated ratio suggests mitochondrial dysfunction
• CSF 2-hydroxyglutarate: Elevated in IDH mutations

Imaging Biomarkers

• FDG-PET: Measures cerebral glucose metabolism, reflecting TCA cycle activity
• MRS: Can detect elevated lactate and reduced N-acetylaspartate

See Also

• [Electron Transport Chain](/mechanisms/electron-transport-chain)
• [Mitochondrial Dynamics](/mechanisms/mitochondrial-dynamics)
• Mitochondrial Dysfunction in Parkinson's Disease
• Energy Metabolism in Neurodegeneration
• Glucose Metabolism in Brain
• [Oxidative Stress in Neurodegeneration](/mechanisms/oxidative-stress-in-neurodegeneration)